INTECH Investment Management’s Astria Therapeutics ATXS Stock Holding History

INTECH Investment Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,939	Closed	-$209K	–	2112
2025 Q4	$209K	Sell	15,939 -3,412	-18%	-$40.8K	﹤0.01%	1965
2025 Q3	$141K	Sell	19,351 -7,978	-29%	-$54K	﹤0.01%	2168
2025 Q2	$146K	Sell	27,329 -6,775	-20%	-$32.8K	﹤0.01%	2194
2025 Q1	$182K	Buy	34,104 +7,000	+26%	+$49K	﹤0.01%	2127
2024 Q4	$242K	Buy	27,104 +6,439	+31%	+$68.4K	﹤0.01%	1941
2024 Q3	$228K	Buy	+20,665	New	+$230K	﹤0.01%	1666

INTECH Investment Management's ATXS Position: Q1 2026 in Review

INTECH Investment Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 15,939 shares — an estimated $209K sold.

INTECH Investment Management first reported a position in ATXS in Q3 2024 and held it in 6 quarters. The position peaked at $242K in Q4 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

INTECH Investment Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
INTECH Investment Management sold 15,939 Astria Therapeutics shares in Q1 2026, an estimated $209K.
INTECH Investment Management first reported a position in Astria Therapeutics in Q3 2024 and held it in 6 quarters.
INTECH Investment Management's Astria Therapeutics position peaked at $242K in Q4 2024.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.